Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry
Authors not listed
Central Hospital, Nancy, France · 2018
Abstract
Oncogeriatric frailty assessment is a multifactorial approach to determine the most appropriate treatment for the health status of elderly cancer patients and this assessment is recommended for patients over 75 years of age.
Oncogeriatric frailty is based on the SIOG-2 (International Society of Geriatric Oncology-2) clinical scale (assessing comorbidities, autonomy, nutrition, cognitive and thymic domains) defining 3 levels of frailty: (1) harmonious aging, (2) vulnerability (reversible stage), (3) fragility (irreversible stage).
So,the management of very old or very frailty patients with poor tolerance or compliance to treatment, often requires to defer standard treatment and monitoring procedures. That is detrimental to these patients prognosis. By contrast with elderly or very old patients without frailty criteria, could benefit from more efficient procedures.
More generally, frailty is associated directly with a cerebral impact on a cognitive or thymic status or indirectly with the cognitive or thymic impacts related with other components (nutritional or autonomy or walking poor status, comorbidities) 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET), is routinely performed in follow-up cancer patients in most cases, including older patients, to detect neoplastic localizations on the whole body. It also accurately quantifies cerebral glycolytic metabolism when early brain recording is performed. Brain metabolism reflects the neuronal synaptic activity. It is generally decreased in particular brain areas due of neurodegenerative damage with a little or no symptom, of thymic involvement particular in depression or during accelerated cerebral aging of vascular origin. The impairment of the brain function of the elderly, as evidenced by 18F-FDG PET, is most often multifactorial, as frailty. Above all, brain changes are visualized with 18F-FDG PET much earlier than using neuropsychological tests, especially for cognitive impairment.
Our hypothesis is that with 18F-FDG PET, performed routinely in the initial assessment in elderly patients with cancer, it is also possible to obtain reliable and objective parameters of brain function and frailty. 18F-FDG PET is already used to identify cognitive and thymic impairment. This exam would help to assess the frailty and to adapt as best oncologic treatments some of which can also be neurotoxic. 18F-FDG PET is therefore related to brain function in frail patients
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Anonymous. (2018). Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry. <em>Central Hospital, Nancy, France</em>. https://clinicaltrials.gov/study/NCT03370809
Vancouver
Anonymous. Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry. Central Hospital, Nancy, France. 2018.
BibTeX
@misc{anon2018Assess,
title = {Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry},
author = {Anonymous},
journal = {Central Hospital, Nancy, France},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Kaohsiung Journal of Medical Sciences 2023
Open access · CC-BY
Vascular frailty, a proposal for new frailty type: A narrative review
Fundación para la Investigación del Hospital Clínico de Valencia 2019
Open access · US-GOV
Study of the Synergy Between Physical Exercise and a Nutritional Supplement for the Prevention and Treatment of Frailty: The ROBUSTNES Study
Centre Hospitalier Universitaire Dijon 2015
Open access · US-GOV
Impact of Nutritional Status and Frailty on the Prognosis of Patients Over 75 Years Old Who Suffered a Stroke
Clinical and Experimental Dermatology 2025
Citation only
Looking beyond chronological age: the importance of frailty in biologic treatment efficacy in older individuals
Journal of the American Geriatrics Society 2004
Open access · OA
Operationalizing a Frailty Index from a Standardized Comprehensive Geriatric Assessment
International Longevity Centre France 2019
Open access · US-GOV